Cancer Res Treat.  2016 Jan;48(1):288-296. 10.4143/crt.2014.297.

A Study of Relationship of Atheroembolic Risk Factors with Postoperative Recovery in Renal Function after Partial Nephrectomy in Patients Staged T1-2 Renal Cell Carcinoma during Median 4-Year Follow-up

Affiliations
  • 1Department of Urology, National Cancer Center, Goyang, Korea.
  • 2Biometric Research Branch, National Cancer Center, Goyang, Korea.
  • 3Department of Urology, Seoul National University Hospital, Seoul, Korea. eslee@snu.ac.kr
  • 4Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.

Abstract

PURPOSE
The objective of this study is to evaluate the relationship of atheroembolic risk factors with postoperative recovery of renal function after on-clamp partial nephrectomy (PN) with warm ischemia in patients with staged T1-2 renal cell carcinoma (RCC).
MATERIALS AND METHODS
A total of 234 patients from 2004 to 2012 were included, and their clinicopathologic and operative parameters, including atheroembolic risk factors were reviewed retrospectively. Renal function, as determined by estimated glomerular filtration rate (eGFR) and measurement of serum creatinine level (Cr) at each scheduled follow-up for a median four years, was compared between the high-risk (HR) group (n=49, > or = five risk factors) and the low-risk (LR) group (n=185, < five risk factors).
RESULTS
Except for baseline renal function and number of risk factors for atheroembolism, differences in characteristics between groups were comparatively insignificant. At 3 months after the operation, Cr and eGFR differed significantly between the two groups (p < 0.05), but no differences were observed afterward. Significant deterioration from baseline in Cr and eGFR was observed in both groups at 1 month after the operation, with a greater change in the HR group (p < 0.05). From measurement to measurement, significantly faster deterioration in Cr and eGFR was observed in the HR group than in the LR group until 6 months after the operation (Cr: LR, 0.02 mg/dL and HR, 0.13 mg/dL; eGFR: LR, 1.50 mL/min/1.73 m2 and HR, 6.38 mL/min/1.73 m2; p < 0.05).
CONCLUSION
The presence of atheroembolic risk factors may negatively influence postoperative recovery of renal function after PN in patients with localized RCC.

Keyword

Renal cell carcinoma; Atherosclerosis; Embolism; Nephron sparing surgery; Renal function; Creatinine

MeSH Terms

Atherosclerosis
Carcinoma, Renal Cell*
Creatinine
Embolism
Embolism, Cholesterol
Follow-Up Studies*
Glomerular Filtration Rate
Humans
Nephrectomy*
Retrospective Studies
Risk Factors*
Warm Ischemia
Creatinine

Figure

  • Fig. 1. Mean creatinine (Cr) levels (A) and estimated glomerular filtration rate (eGFR) calculated using the Modification of Diet in Renal Disease (MDRD) equation (B) at the time of the postoperative follow-up of the high-risk and low-risk groups of atheroembolism are shown along with their comparative p-values for each follow-up month. sCr, serum creatinine; RF, risk factors.

  • Fig. 2. Postoperative changes in the mean creatinine (Cr) levels (A) and estimated glomerular filtration rate (eGFR) calculated using the Modification of Diet in Renal Disease (MDRD) equation (B) differences compared to the baseline values are shown along with the comparative p-values for each follow-up month between high- and low-risk groups of atheroembolism. sCr, serum creatinine; RF, risk factors.


Reference

References

1. Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol. 2010; 58:398–406.
Article
2. Leslie S, Goh AC, Gill IS. Partial nephrectomy: contemporary indications, techniques and outcomes. Nat Rev Urol. 2013; 10:275–83.
3. Malcolm JB, Bagrodia A, Derweesh IH, Mehrazin R, Diblasio CJ, Wake RW, et al. Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy. BJU Int. 2009; 104:476–81.
Article
4. MacLennan S, Imamura M, Lapitan MC, Omar MI, Lam TB, Hilvano-Cabungcal AM, et al. Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol. 2012; 62:1097–117.
Article
5. Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, et al. Comparison of warm ischemia versus no ischemia during partial nephrectomy on a solitary kidney. Eur Urol. 2010; 58:331–6.
Article
6. Kim SP, Thompson RH. Kidney function after partial nephrectomy: current thinking. Curr Opin Urol. 2013; 23:105–11.
7. Kim SH, Lee SE, Hong SK, Jeong CW, Park YH, Kim YJ, et al. Incidence and risk factors of chronic kidney disease in korean patients with t1a renal cell carcinoma before and after radical or partial nephrectomy. Jpn J Clin Oncol. 2013; 43:1243–8.
Article
8. Kates M, Badalato GM, McKiernan JM. Renal functional outcomes after surgery for renal cortical tumors. Curr Opin Urol. 2011; 21:351–5.
Article
9. Thurlbeck WM, Castleman B. Atheromatous emboli to the kidneys after aortic surgery. N Engl J Med. 1957; 257:442–7.
Article
10. Scolari F, Ravani P. Atheroembolic renal disease. Lancet. 2010; 375:1650–60.
Article
11. Mayo RR, Swartz RD. Redefining the incidence of clinically detectable atheroembolism. Am J Med. 1996; 100:524–9.
Article
12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130:461–70.
13. Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009; 182:844–53.
Article
14. de Mast Q, Beutler JJ. The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review. J Hypertens. 2009; 27:1333–40.
Article
15. Dumaine RL, Montalescot G, Steg PG, Ohman EM, Eagle K, Bhatt DL, et al. Renal function, atherothrombosis extent, and outcomes in high-risk patients. Am Heart J. 2009; 158:141–8.e1.
Article
16. Meyrier A. Cholesterol crystal embolism: diagnosis and treatment. Kidney Int. 2006; 69:1308–12.
Article
17. Scolari F, Ravani P, Pola A, Guerini S, Zubani R, Movilli E, et al. Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol. 2003; 14:1584–90.
Article
18. Mittal BV, Alexander MP, Rennke HG, Singh AK. Atheroembolic renal disease: a silent masquerader. Kidney Int. 2008; 73:126–30.
Article
19. Modi KS, Rao VK. Atheroembolic renal disease. J Am Soc Nephrol. 2001; 12:1781–7.
Article
20. Frock J, Bierman M, Hammeke M, Reyes A. Atheroembolic renal disease: experience with 22 patients. Nebr Med J. 1994; 79:317–21.
21. Hamscho N, Wilhelm A, Dobert N, Menzel C, Gossmann J, Berner U, et al. Residual kidney function after donor nephrectomy: assessment by 99mTc-MAG3-clearance. Nuklearmedizin. 2005; 44:200–4.
22. Nizet A. The mechanisms of fast renal compensation. Pflugers Arch. 1973; 341:209–17.
Article
23. Choi KH, Yoon YE, Kim KH, Han WK. Contralateral kidney volume change as a consequence of ipsilateral parenchymal atrophy promotes overall renal function recovery after partial nephrectomy. Int Urol Nephrol. 2015; 47:25–32.
Article
24. Sharma N, O'Hara J, Novick AC, Lieber M, Remer EM, Herts BR. Correlation between loss of renal function and loss of renal volume after partial nephrectomy for tumor in a solitary kidney. J Urol. 2008; 179:1284–8.
Article
25. Thompson RH, Lane BR, Lohse CM, Leibovich BC, Fergany A, Frank I, et al. Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology. 2012; 79:356–60.
Article
Full Text Links
  • CRT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr